Despite many available treatments, dry eye disease (DED) remains one of the most underdiagnosed and undertreated conditions in eyecare. Clinical trials to inform treatment development often have stric
Research-based insights into predictive signs, clinical tests and global practice patterns for dry eye disease
As a practice owner or manager, you know the feeling of multitasking. Day-to-day, working on your business fundamentals generally takes a back seat to the primary goal of taking care of your patients. The good thing is it doesn't take as much time, effort or money to get your practice to-do lists do
Dry eye disease (DED) is multifactorial in origin and, while intrinsic ocular surface pathology often garners the most attention, mechanical contributors, particularly those related to eyelid position and function, are sometimes underrecognised. In clinical oculoplastics practice, eyelid malposition
Dry, gritty, burning eyes? The most common culprit is meibomian gland dysfunction (MGD). These tiny glands, nestled within our eyelids, should secrete a lubricous oily substance termed meibum, which p
Dani Fennessy on her sight- and life-saving journey with IIH
After navigating the road tunnel to the centre of Ellerslie Racecourse and the pedestrian tunnel back to the other side on a cold, wet Sunday morning, the warm lights of the brick-built Tote On Ascot
Chronic inflammation is known to play a key role in severe dry eye disease (DED), contributing to a self-perpetuating cycle of ocular surface damage. Inflammatory mediators and proteases released are
Hosted at a new venue, the Maritime Room, the 9th Glaucoma New Zealand (GNZ) Symposium delivered an excellent programme with loads of great tips and content. The audience of ophthalmologists, optometr
Ensuring evidence-based best practice reaches patients, both locally and globally, is at the heart of what we do as clinical educators. At the 2024 Tear Film & Ocular Surface Society (TFOS) conference in Venice, a chance meeting between then BCLA president Sarah Farrant, Indian ophthalmologist A
An in-practice perspective on the clinical utility of topical ciclosporin for dry eye disease
Recurrent chalazia present a challenge in clinical practice. Photobiomodulation is a novel approach to management, which, as described in this patient case, can offer encouraging results. A 42-year-
